Home » Topics » BioWorld Science

BioWorld Science
RSS

Four series of delta opioid ligands prepared by AstraZeneca scientists

June 18, 2004

Febuxostat reported to reduce serum urate levels of gout patients

June 18, 2004

Novel ecstasy analogues may be promising antiparkinsonian agents

June 18, 2004

Analgesic efficacy of HCT-3012 in osteoarthritis of the knee

June 18, 2004

FDA accepts for filing Surfaxin NDA

June 18, 2004

Insegia chosen as trade name for G17DT

June 18, 2004

Noven and Shire to proceed with further development of MethyPatch

June 18, 2004

Labopharm to apply polymeric nanodelivery systems technology to cancer drug

June 18, 2004

New phase III hemodialysis trial for ferumoxytol iron replacement therapy

June 18, 2004

Phase II trial of Xcytrin for recurrent low-grade NHL under way

June 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...